TY - JOUR
T1 - Optical Control of Cytokine Production Using Photoswitchable Galactosylceramides
AU - Hartrampf, Nina
AU - Seki, Toshiyuki
AU - Baumann, Andreas
AU - Watson, Philip
AU - Vepřek, Nynke A.
AU - Hetzler, Belinda E.
AU - Hoffmann-Röder, Anja
AU - Tsuji, Moriya
AU - Trauner, Dirk
N1 - Publisher Copyright:
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
PY - 2020/4/6
Y1 - 2020/4/6
N2 - α-Galactosylceramides are glycosphingolipids that show promise in cancer immunotherapy. After presentation by CD1d, they activate natural killer T cells (NKT), which results in the production of a variety of pro-inflammatory and immunomodulatory cytokines. Herein, we report the synthesis and biological evaluation of photochromic derivatives of KRN-7000, the activity of which can be modulated with light. Based on established structure–activity relationships, we designed photoswitchable analogues of this glycolipid that control the production of pro-inflammatory cytokines, such as IFN-γ. The azobenzene derivative α-GalACer-4 proved to be more potent than KRN-7000 itself when activated with 370 nm light. Photolipids of this type could improve our mechanistic understanding of cytokine production and could open new directions in photoimmunotherapy.
AB - α-Galactosylceramides are glycosphingolipids that show promise in cancer immunotherapy. After presentation by CD1d, they activate natural killer T cells (NKT), which results in the production of a variety of pro-inflammatory and immunomodulatory cytokines. Herein, we report the synthesis and biological evaluation of photochromic derivatives of KRN-7000, the activity of which can be modulated with light. Based on established structure–activity relationships, we designed photoswitchable analogues of this glycolipid that control the production of pro-inflammatory cytokines, such as IFN-γ. The azobenzene derivative α-GalACer-4 proved to be more potent than KRN-7000 itself when activated with 370 nm light. Photolipids of this type could improve our mechanistic understanding of cytokine production and could open new directions in photoimmunotherapy.
KW - azobenzenes
KW - cancer immunotherapy
KW - galactosyl ceramides
KW - natural killer T cells
KW - photopharmacology
UR - http://www.scopus.com/inward/record.url?scp=85081672741&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081672741&partnerID=8YFLogxK
U2 - 10.1002/chem.201905279
DO - 10.1002/chem.201905279
M3 - Article
C2 - 31788876
AN - SCOPUS:85081672741
SN - 0947-6539
VL - 26
SP - 4476
EP - 4479
JO - Chemistry - A European Journal
JF - Chemistry - A European Journal
IS - 20
ER -